Clinical Trial Update: Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating inhaled nitric oxide for acute hypoxemic respiratory failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemic Respiratory Failure

Drugs mentioned

• INOmax (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Respiratory Insufficiency, Anoxemia | Phase 3 | Status: TERMINATED